Literature DB >> 10508168

The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence.

K J Purdie1, J Pennington, C M Proby, S Khalaf, E M de Villiers, I M Leigh, A Storey.   

Abstract

An aetiological role has been proposed for human papillomavirus (HPV) in skin carcinogenesis within the immunosuppressed patient population. To examine this possibility, we have focused on an HPV type that, to date, has been identified only in the cutaneous lesions of renal transplant recipients despite a high degree of sequence homology with other HPVs commonly found in warts in the general population. We report that the non-coding region of this virus, HPV type 77, contains a consensus binding site for the tumour suppressor protein p53, and we show by gel-retardation analysis that this sequence does indeed bind p53. Furthermore, using reporter gene assays, we demonstrate that HPV77 promoter activity is stimulated by UV radiation and that this response is mediated through the p53 binding site. This is the first report of a p53-dependent positive response element within a viral genome. Our results suggest a possible novel mechanism by which specific types of HPV might act as cofactors with UV radiation in cutaneous transformation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508168      PMCID: PMC1171605          DOI: 10.1093/emboj/18.19.5359

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  18 in total

1.  [Clinical algorithm of cutaneous extragenital wart treatment].

Authors:  A Rübben
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

Review 2.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

Review 3.  Pathogenesis of nonmelanoma skin cancers in organ transplant recipients.

Authors:  Mohammad Athar; Stephanie B Walsh; Levy Kopelovich; Craig A Elmets
Journal:  Arch Biochem Biophys       Date:  2011-01-11       Impact factor: 4.013

Review 4.  Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.

Authors:  N Di Girolamo
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

5.  Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo
Journal:  Hum Immunol       Date:  2019-05-06       Impact factor: 2.850

6.  Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.

Authors:  S Jackson; C Harwood; M Thomas; L Banks; A Storey
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

7.  Merkel cell polyomavirus small T antigen mRNA level is increased following in vivo UV-radiation.

Authors:  Ariane Mogha; Alain Fautrel; Nicolas Mouchet; Na Guo; Sébastien Corre; Henri Adamski; Eric Watier; Laurent Misery; Marie-Dominique Galibert
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

8.  Arsenic exposure and human papillomavirus response in non-melanoma skin cancer Mexican patients: a pilot study.

Authors:  J Alberto Rosales-Castillo; Leonor C Acosta-Saavedra; Rosantina Torres; Jesús Ochoa-Fierro; Víctor H Borja-Aburto; Lizbeth Lopez-Carrillo; Gonzalo G Garcia-Vargas; Georgina B Gurrola; Mariano E Cebrian; Emma S Calderón-Aranda
Journal:  Int Arch Occup Environ Health       Date:  2004-07-03       Impact factor: 3.015

9.  Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion?

Authors:  Georgi Tchernev; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2014-04-11

10.  Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome.

Authors:  Jui-Cheng Hsieh; Ryan Kuta; Courtney R Armour; Paul E Boehmer
Journal:  Virology       Date:  2014-05-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.